IND

Example Definitions of "IND"
IND. Shall mean an investigational new drug application, clinical study application, clinical trial exemption or similar application or submission for approval to conduct human clinical investigations filed with a Regulatory Authority in any country.
IND. Shall The term "IND" shall mean an investigational new drug application, clinical study trial application, clinical trial exemption exemption, or similar application or submission for approval to conduct human clinical investigations filed with or submitted to a Regulatory Authority regulatory authority in any country.
IND. Shall mean an An investigational new drug application, clinical study application, clinical trial exemption or similar application or submission for approval to conduct human clinical investigations filed with a Regulatory Authority in any country. Authority.
IND. Shall mean an investigational new drug An FDA Investigational New Drug application, clinical study application, clinical trial exemption Clinical Study Application, Clinical Trial Exemption, or similar application or submission for approval to conduct human clinical investigations filed with or submitted to a Regulatory Regulator Authority in any country. country in conformance with the requirements of such Regulatory Authority.
View Variations
IND. The Investigational New Drug Application filed or to be filed with the FDA as described in Title 21 of the U.S. Code of Federal Regulations, Part 312, and the equivalent application in the jurisdictions outside the United States, including an Investigational Medicinal Product Dossier filed or to be filed with the EMA.
IND. The Investigational New Drug Application filed or to be filed with the FDA as described in Title 21 of the U.S. Code of Federal Regulations, Part 312, and the equivalent application in the jurisdictions outside the United States, including an Investigational Medicinal Product Dossier filed or to be filed with the EMA. States.
IND. The Investigational New Drug Application filed or to be filed with the FDA as described in Title 21 of the U.S. Code of Federal Regulations, Part 312, and the equivalent application in the jurisdictions outside the United States, including an Investigational Medicinal Product Dossier filed or to be filed with the EMA. Regulatory Authorities in the European Union.
IND. The Means the Investigational New Drug Application filed or to be filed with the FDA as described in Title 21 of the U.S. Code of Federal Regulations, Part 312, and the equivalent application in the jurisdictions outside the United States, including an Investigational "Investigational Medicinal Product Dossier Dossier" filed or to be filed with the EMA.
View Variations
IND. Means an investigational new drug application as defined in the FD&C Act and applicable regulations promulgated thereunder by the FDA or (b) the equivalent application to the equivalent Regulatory Authority in any other regulatory jurisdiction, the filing of which is necessary to initiate or conduct clinical testing of a pharmaceutical product in humans in such jurisdiction.
IND. Means (a) an investigational new drug application Investigational New Drug Application as defined in the FD&C Act and applicable regulations promulgated thereunder by the FDA FDA, or (b) the equivalent application to the equivalent Regulatory Authority agency in any other regulatory jurisdiction, the filing of which is necessary to initiate or conduct clinical testing of a pharmaceutical product in humans in such jurisdiction. jurisdiction
View Variations
IND. An Investigational New Drug application required to commence human clinical testing of a product submitted to the FDA
IND. An Investigational New Drug application or similar application required to commence human clinical testing of a product submitted to the FDA FDA, or its foreign equivalent
View Variations
IND. An Investigational New Drug Application filed with the FDA to begin clinical studies of a new drug in humans (pursuant to 21 CFR 312, et. seq., as amended).
IND. An Investigational New Drug Application filed with the FDA to begin clinical studies of a new drug in humans (pursuant to 21 CFR 312, et. seq., as amended), and/or the corresponding application with a corresponding regulatory agency in a country other than the United States, as applicable, and/or any successor application (s)
IND. An investigational new drug application, as described in 21 C.F.R. Section 312.23, filed for purposes of conducting clinical trials in accordance with the requirements of the United States Food, Drug and Cosmetic Act of 1938, as amended, and the rules and regulations promulgated thereunder, including all supplements and amendments thereto relating to the use of the Licensed Product, ownership of which shall be transferred to Teva by Rexahn upon and subject to issuance of the License Notice.
IND. An Investigational New Drug application filed with the FDA and any equivalent foreign filing
IND. An Investigational New Drug application for Bulk Drug Substance, as defined in the FD&C Act or FDA Regulations (21 CFR 314).
IND. An Investigational New Drug application for Product, as defined in the FD&C Act or FDA Regulations (21 CFR)
All Definitions